A small molecule-regulated guanine nucleotide exchange factor

Journal of the American Chemical Society

Volumn 132, Issue 3, 2010, Pages 938-940

  Goreshnik, Inna ^a   Maly, Dustin J ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-APOPTOTIC PROTEIN; ATTRACTIVE STRATEGIES; CATALYTIC ACTIVITY; DOSE-DEPENDENT; DOSE-DEPENDENT MANNER; GENETIC METHODS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; INTRACELLULAR PROTEINS; NUCLEOTIDE EXCHANGE; PHARMACOLOGICAL AGENTS; REGULATORY DOMAIN; SMALL MOLECULES;

BACTERIOPHAGES; BIOCHEMICAL ENGINEERING; CATALYSTS; ENZYMES; MOLECULES; NUCLEOTIDES; POSITIVE IONS;

SIGNAL TRANSDUCTION;

GUANINE NUCLEOTIDE EXCHANGE FACTOR;

ARTICLE; CATALYSIS; CELL MEMBRANE PERMEABILITY; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; SYNTHESIS;

ANILINE COMPOUNDS; BCL-X PROTEIN; BINDING SITES; BIPHENYL COMPOUNDS; GUANINE NUCLEOTIDE EXCHANGE FACTORS; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; NITROPHENOLS; PEPTIDE FRAGMENTS; PIPERAZINES; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

EID: 76149119813     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja907886v     Document Type: Article

References (22)

1. (a) Banaszynski, L. A.; Wandless, T. J. Chem. Biol. 2006, 13, 11-21.
2. (b) Schwartz, E. C.; Saez, L.; Young, M. W.; Muir, T. W. Nat. Chem. Biol. 2007, 3, 50-54.
3. (c) Knight, Z. A.; Shokat, K. M. Cell 2007, 128, 425-430.
4. (d) Pratt, M. R.; Schwartz, E. C.; Muir, T. W. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 11209-11214.
5. (e) de Graffenried, C. L.; Laughlin, S. T.; Kohler, J. J.; Bertozzi, C. R. Proc. Natl. Acad. Sci. U.S.A. 2004, 101, 16715-16720.
6. An elegant method for directly engineering the allosteric regulation of enzyme activity through interface design has recently been described: Lee, J.; Natarajan, M.; Nashine, V. C.; Socolich, M.; Vo, T.; Russ, W. P.; Benkovic, S. J.; Ranganathan, R. Science 2008, 322, 438-442.
7. Lim, W. A. Curr. Opin. Struct. Biol. 2002, 12, 61-68.
8. (a) Dömling, A. Curr. Opin. Chem. Biol. 2008, 12, 281-291.
9. (b) Wells, J. A.; McClendon, C. L. Nature 2007, 450, 1001-1009.
10. (a) Muchmore, S. W.; Sattler, M.; Liang, H.; Meadows, R. P.; Harlan, J. E.; Yoon, H. S.; Nettesheim, D.; Chang, B. S.; Thompson, C. B.; Wong, S. L.; Ng, S. L.; Fesik, S. W. Nature 1996, 381, 335-341.
11. (b) Sattler, M.; Liang, H.; Nettesheim, D.; Meadows, R. P.; Harlan, J. E.; Eberstadt, M.; Yoon, H. S.; Shuker, S. B.; Chang, B. S.; Minn, A. J.; Thompson, C. B.; Fesik, S. W. Science 1997, 275, 983-986.
12. (a) Oltersdorf, T.; et al. Nature 2005, 435, 677-681.
13. (b) Shoemaker, A. R.; et al. Cancer Res. 2006, 66, 8731-8739.
14. (c) Wendt, M. D.; et al. J. Med. Chem. 2006, 49, 1165-1181.
15. (d) Bruncko, M.; et al. J. Med. Chem. 2007, 50, 641-662.
16. Lim and co-workers have previously demonstrated that Intersectin can be engineered to be regulated by an artificial regulatory module: Yeh, B. J.; Rutigliano, R. J.; Deb, A.; Bar-Sagi, D.; Lim, W. A. Nature 2007, 447, 596-600.
17. (a) Rossman, K. L.; Der, C. J.; Sondek, J. Nat. Rev. Mol. Cell Biol. 2005, 6, 167-180.
18. (b) Jaffe, A. B.; Hall, A. Annu. Rev. Cell Dev. Biol. 2005, 21, 247-269.
19. Lee, E. F.; Czabotar, P. E.; Smith, B. J.; Deshayes, K.; Zobel, K.; Colman, P. M.; Fairlie, W. D. Cell Death Differ. 2007, 14, 1711-1713.
20. Zamanian, J. L.; Kelly, R. B. Mol. Biol. Cell 2003, 14, 1624-1637.
21. Morreale, A.; Venkatesan, M.; Mott, H. R.; Owen, D.; Nietlispach, D.; Lowe, P. N.; Laue, E. D. Nat. Struct. Biol. 2000, 7, 384-388.
22. Tahir, S. K.; Yang, X.; Anderson, M. G.; Morgan-Lappe, S. E.; Sarthy, A. V.; Chen, J.; Warner, R. B.; Ng, S. C.; Fesik, S. W.; Elmore, S. W.; Rosenberg, S. H.; Tse, C. Cancer Res. 2007, 67, 1176-1183.